Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF II.

← Research Home← More in this subcategory
Europe PMCPublished 2026Medicine & Clinical ResearchDisease Diagnosis & Prevention
Journal
JACC. Heart failure
Record source
Europe PMC Research Library

Abstract / Description

BackgroundPathophysiologic features associated with increased risk in heart failure with preserved ejection fraction (HFpEF) may reflect distinct phenotypes or disease stages related to heart failure (HF) duration.ObjectivesThis study aims to determine how duration of HF diagnosis influences cardiac structure and function, hemodynamics, risk for worsening HF, and treatment response.MethodsBaseline cardiac structure and function, hemodynamics, and outcomes following randomization were evaluated among individuals participating in the REDUCE LAP-HF II trial (N = 626): patients with HF, left ventricular ejection fraction ≥40%, and exercise pulmonary capillary wedge pressure ≥25 mm Hg, categorized by HF duration: 3 years.ResultsLonger HF duration was associated with greater cardiac remodeling and dysfunction, including lower left ventricular global longitudinal strain (16.4% [Q1-Q3: 14.3%-18.6%] vs 17.7% [Q1-Q3: 15.4%-20.0%] vs 18.4% [Q1-Q3: 16.3%-20.5%]; P < 0.0001) and right ventricular free wall strain (20.8% [Q1-Q3: 16.7%-24.6%] vs 22.2% [Q1-Q3: 17.6%-26.1%] vs 24.4% [Q1-Q3: 19.2%-27.2%]; P < 0.0001), and more biatrial myopathy (48.8% vs 40.8% vs 28.2%; P < 0.0001). Resting pulmonary capillary wedge pressure elevation was more common with longer duration (75.8% vs 70.7% vs 64.9%; P = 0.024). These findings were confirmed in an independent sample of patients with HFpEF undergoing evaluation at Mayo Clinic. HF event risk increased with longer duration (HR: 1.70 [95% CI: 1.17-2.48]; P = 0.006 for >3 years vs
Read original research ↗Open DOI ↗